Gynecomastia Treatment Market Prophesied to Grow at a Faster Pace by 2028
Posted by researchreportinsights12 on May 13th, 2019
Gynecomastia refers to the proliferation of the glandular tissue in the male breast or the enlargement of the male breast. The major cause of gynecomastia is the hormonal imbalance which occurs between the estrogen level and androgen activity amongst the males. Several medications such as anti-androgens, anti-depressants, etc. are also associated with the cause of gynecomastia. Gynecomastia is common in infancy, puberty and middle-aged. The symptoms of gynecomastia include swelling, nipple discharge, pain, etc. Overuse of herbal products such as tea tree or lavender used in shampoo, soaps, and lotions are also associated with gynecomastia.
Increasing intake of alcohol is one of the major factor contributing towards the growth of gynecomastia treatment market. Intake of certain medications such as anti-depressants, anabolic steroids, etc. are the main cause of gynecomastia and are expected to increase the growth of gynecomastia treatment market. Various factors such as poverty, poor lifestyle habits lead to malnutrition, which can drive the gynecomastia market. Increasing healthcare awareness is also expected to increase the growth of gynecomastia treatment market. The increasing prevalence of liver and kidney disorders such as liver cirrhosis, liver failures, kidney failures are expected to boost the gynecomastia treatment market. Increasing geriatric population is another factor which can contribute to the growth of gynecomastia treatment market. The geriatric population is prone to hormonal changes that occur with normal aging and can cause gynecomastia. Increasing sports and physical activities can also lead to the growth of gynecomastia treatment market as sports person or teenagers engaged in various physical activities, are expected to take anabolic steroids in a large quantity, to enhance the athlete performance, and can ultimately increase the growth of gynecomastia treatment market.
Request For Report Sample: https://www.researchreportinsights.com/connectus/sample?flag=B&rep_id=50
Lack of awareness in some emerging regions or rural areas is a factor which can hamper the growth of gynecomastia treatment market. Unavailability of medications is another factor which can restrain the growth of gynecomastia treatment market. The global Gynecomastia Treatment market is segmented on basis of treatment type, end user and geographic region:
Segmentation by Treatment Type
Tamoxifen,,Raloxifene,,Aromatase Inhibitors,,OthersSurgical Treatment
Segmentation by End User
Hospitals Pharmacies,,Retail Pharmacies,,Drug Stores,,Online Pharmacies
Based on the product type, the Gynecomastia Treatment market has been segmented into drugs and surgeries. The medications used for the treatment of gynecomastia include tamoxifen, Raloxifene, Aromatase Inhibitors, and other medications. Tamoxifen is generally taken for the treatment of severe gynecomastia. Based on the end user, the gynecomastia treatment market has been segmented into hospital pharmacies, retail pharmacies, drug stores, and online pharmacies. Hospital pharmacies and retail stores are expected to hold the largest revenue share in the gynecomastia treatment market.
Based on geography, the global Gynecomastia Treatment market has been divided into a few main regions, which includes North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa. North America, is expected to register large revenue shares in global Gynecomastia Treatment market because of the advanced healthcare infrastructure and easy availability of treatment facilities. Europe is expected to hold the second largest market share because of the increasing geriatric population. The Asia Pacific can also show a large revenue share in the Gynecomastia Treatment market because of the increasing healthcare awareness amongst the people and increasing research and developmental activities
There are many pharmaceutical companies manufacturing gynecomastia treatment drugs. Some of the big pharmaceutical companies involved in the manufacture of Gynecomastia Treatment are Cadila Pharmaceuticals Ltd, Sun Pharmaceuticals Industries Ltd., Zydus Cadila Healthcare Ltd., Biochem Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Micro Nova Pharmaceuticals Ltd, Kee Pharma Ltd.etc.,.
Research Report Insights (RRI) is a leading market intelligence and consulting firm. We deliver a host of services including custom research reports, syndicated research reports, and consulting services which are personalised in nature. RRI delivers a complete packaged solution to clients; this combines current market intelligence, technology inputs, statistical anecdotes, valuable growth insights, 360-degree view of the competitive framework, and anticipated market trends.
Our research services cover global as well as regional emerging markets such as BRICS, GCC, and ASEAN. Our offerings cover a broad spectrum of verticals which include Oil and Gas, Chemicals, Materials, Energy, Technology, Automotive, and Retail. The operating model of RRI blends cross-disciplinary research experience to deploy insightful, in-depth, and actionable research.
Research Report Insights
27 Upper Pembroke Street,
Dublin 2, Ireland
Phone: +353-1-6111-593Also See: Treatment Market, Gynecomastia Treatment, Gynecomastia Include, Global Gynecomastia, Treatment, Market, GynecomastiaTop Searches - Trending Searches - New Articles - Top Articles - Trending Articles - Featured Articles - Top Members
Copyright © 2019 Uberant.com560,117 total articles and counting.